ROYAL BANK OF CANADA - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 61 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2022$1,000
-75.0%
3,801
+108.4%
0.00%–
Q1 2022$4,000
-85.7%
1,824
-73.0%
0.00%–
Q4 2021$28,000
-24.3%
6,746
+70.3%
0.00%–
Q3 2021$37,000
+27.6%
3,961
+142.1%
0.00%–
Q2 2021$29,000–1,636–0.00%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders